1. P595 Clinical effectiveness of golimumab: Interim analysis of the observational study of patients with ulcerative colitis on golimumab in the Swedish National Quality Registry for IBD–GO-SWIBREG. (16th January 2018) Authors: Eriksson, C; Bergemalm, D; Vigren, L; Nilsson, L; Visuri, I; Hjortswang, H; Udumyan, R; Almer, S; Seddighzadeh, M; Hertervig, E; Karlén, P; Strid, H; Halfvarson, J Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P649 Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG). (25th January 2019) Authors: Visuri, I; Eriksson, C; Mårdberg, E; Grip, O; Gustavsson, A; Hjortswang, H; Karling, P; Montgomery, S; Myrelid, P; Olén, O; Ludvigsson, J F; Halfvarson, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗